MARLBOROUGH, Mass., Feb. 12, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences.
On February 25, 2021, Dan Brennan, executive vice president and chief financial officer, and Susie Lisa, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst at the virtual SVB Leerink 10th Annual Global Healthcare Conference. The session will begin at approximately 10:40 a.m. EST.
On March 1, 2021, Meghan Scanlon, senior vice president and president, Urology and Pelvic Health, and Susie Lisa will participate in a 30-minute question-and-answer session with the host analyst at the virtual Cowen 41st Annual Health Care Conference. The session will begin at approximately 2 p.m. EST.
About Boston Scientific Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.